FDA-approved transcatheter heart valve offered to patients

8 julio 2014

The new FDA-approved transcatheter heart valve therapy helps patients with aortic valve disease who are at high risk to undergo open-heart surgery. The CoreValve System replaces a diseased aortic heart valve through a minimally invasive procedure, without open-heart surgery and without surgical removal of the diseased valve. The device is typically inserted via an artery in the leg or upper chest, and then guided through the arteries into the heart.